Caricamento...
Prospective analysis of 30‐day mortality following palliative chemotherapy at a tertiary cancer centre
BACKGROUND: Thirty‐day mortality after chemotherapy has been suggested as a marker of quality in oncology care. Retrospective audits worldwide have put this figure at between 8.1% and 43%, with previous retrospective Australian audits putting this figure at between 3.4% and 18%. To date, there has n...
Salvato in:
| Pubblicato in: | Cancer Rep (Hoboken) |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7941511/ https://ncbi.nlm.nih.gov/pubmed/32729198 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cnr2.1135 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|